David Han

David Han is a Senior Managing Director at One Equity Partners (OEP), a private equity firm based in New York.13 Here are some key details about his career and role:

Professional Background

David Han joined OEP in 2005 and has since become a prominent figure in the firm.13 His responsibilities include:

• Serving as a member of the Investment Committee
• Participating in the Operating Committee
• Contributing to the Valuation Committee

Investment Experience

Han has led several significant investments for OEP, including:

• OCI
• Columbian Chemicals
• Pirelli Tyre
• Celltrion Healthcare
• Sonneborn
• PeroxyChem
• ORS Medco

He currently serves on the Board of Directors for Celltrion Healthcare and ORS Medco.1

Prior Experience

Before joining OEP, David Han had an extensive 18-year career in investment banking.1 His previous roles included:

• Associate at Lehman Brothers
• Vice President at Morgan Stanley
• Managing Director at Smith Barney
• Managing Director at Greenhill
• Managing Director at Credit Suisse First Boston

Education

Han holds impressive academic credentials:

• M.B.A. from Harvard Business School
• B.A. in Economics from Cornell University1

Recent Developments

It's worth noting that David Han has been involved in a legal dispute with One Equity Partners. In 2023, he claimed to have been wrongfully ousted and deprived of his partnership stake in the $10 billion private equity firm.2 As of February 2024, reports suggest that OEP and Han were nearing a settlement, though the details had not been finalized at that time.2